You are here: Industry Insights > Healx

News List

Healx secures option to license rights from Ovid to develop gaboxadol pharmaceutical-business-review
February 09, 2022
Healx, an AI-powered, technology company involved in the next generation of drug discovery...
Healx links with CTF to develop neurofibromatosis therapies pharmatimes
April 16, 2020
Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).
Boehringer partners with Healx for AI-based drug discovery pharmaceutical-technology
December 11, 2019
German pharmaceutical company Boehringer Ingelheim has partnered with UK-based drug technology firm Healx to identify approaches to treat rare neurological disorders.
Healx reels in $10M in series A funding for work on rare diseases fiercebiotech
July 31, 2018
Healx, a U.K.-based company that works with patient advocacy groups to repurpose drugs for rare diseases, reeled in $10 million in series A funding it plans to use to hire more researchers and enhance its AI platform.